2011 International Expert Meeting on Large Congenital Melanocytic Nevi

描述（由申请人提供）：在过去的几年中，在了解大型先天性黑素细胞痣（CMN）及其相关疾病的起源和临床管理方面取得了相当大的进展。来自遗传学、细胞生物学、流行病学和治疗研究的新成果，是由美国和欧洲国家的团体带头，由世界各地的患者倡议所作出的巨大努力所促成的。所有这些参与者之间存在巨大的协同潜力。在德国蒂宾根举行的会议旨在使基础生物学和临床医学领域的杰出研究人员和医生能够交流最新的、有时未发表的信息。本次会议将促进和协调与会者之间的新颖、跨学科和国际合作。美国和欧洲主要倡导团体的领导人将出席会议，代表患者参与那些转化研究项目，这些项目将在会议期间奠定基础。这些结果将对改善这种毁容和潜在威胁生命的疾病患者的诊断和治疗做出重要贡献。

DESCRIPTION (provided by applicant): In the last years, considerable progress has been made in understanding the origins and clinical management of large congenital melanocytic nevi (CMN) and its related disorders. New results from genetics, cell biology, epidemiology, and therapeutic research are flanked by enormous efforts made by patient initiatives around the world, spearheaded by groups in the U.S. and European countries. There is enormous potential for synergy between all of these players. The conference in Tubingen, Germany aims to enable the exchange of the most up-to-date, sometimes unpublished information from basic biology and clinical medicine among outstanding researchers and physicians in the field. This conference will foster and enable the coordination of novel, interdisciplinary and international collaborations among participants. The leadership of major U.S. and European advocacy groups will attend the conference, to represent patient participation in those translational research projects for which the groundwork will be laid during the conference. These outcomes will make important contributions to the improvement of diagnosis and treatment for patients with this disfiguring and potentially life-threatening disease.